TAS 2016: Prayas by Sanofi-Aventis in India

50 %
50 %
Information about TAS 2016: Prayas by Sanofi-Aventis in India

Published on May 15, 2016

Author: asa2107

Source: slideshare.net

1. TAS TAS 2016 In-house Selection Process Prayas by Sanofi-Aventis in India

2. TAS Scheme of the presentation STRATEGIC INTENT  Please comment on the strategic intent behind conceptualisation of the Prayas Initiative by Sanofi- Aventis.  What do you think were the risks involved in this initiative right from the beginning? • Leaders in the market. • Involve partnerships within all service providers. • Stagnant growth in urban market. • 2nd biggest pharma market after US - USD 55 bn by 2020 .  Rising income level in rural areas.  Growing Patient base.  Improvement in healthcare infrastructure.  Wider Insurance Cover.  Bridging Diagnosis- Treatment gap.  CME to doctors for Awareness to Advocacy to Adoption.

3. TAS Scheme of the presentation STRATEGIC INTENT  Please comment on the strategic intent behind conceptualisation of the Prayas Initiative by Sanofi- Aventis.  What do you think were the risks involved in this initiative right from the beginning? Universal Risks Specific to Prayas • Low Govt. spend. • Poor Healthcare infrastructure. • Poor basic hygiene and living conditions. • Extensive availability of spurious drugs. • Tangible returns from a socially based model. • Presence of players - variety of products, high cost advantage, very high penetration reach and coverage • Unorthodox/Unethica l promotional practices

4. TAS Scheme of the presentation VALUE PROPOSITION  What were the value propositions for each of the key stakeholders of Prayas initiative?  Distinguish between the approaches of value creation by MNCs and Indian companies in this specific industry sector. Support your arguments with statements from the case. KOLS • Name associated with a Social Objective. MENTORS • Network and collaborate with the experts. • Certification by ACP MENTEES PATIENTS SANOFI- AVENTIS • Promotion of brand in Rural areas, • Mentee Doctors prescribe Sanofi’s Productions out of gratitude. • Opportunity to upgrade medical knowledge and practice • Advanced treatment • Diagnostic treatment than symptomatic treatment.

5. TAS Scheme of the presentation VALUE PROPOSITION  What were the value propositions for each of the key stakeholders of Prayas initiative?  Distinguish between the approaches of value creation by MNCs and Indian companies in this specific industry sector. Support your arguments with statements from the case. The GAME PLAN of Competitors: • Disease education focus :Focus on disease education rather than health education. • Smaller packs since usage was in small quantity but frequent. Many are daily wage earners/low income consumers and could not afford to buy in bulk. • Medical awareness directly to end users (patients) -. (Novartis) • Entering with established product portfolio (Chronic care products) eg Eli-lilly and Novo • Mobile clinics to promote drugs (Novo-Novardisk) • Collaborating with NGOs (Eli-lilly, Nicholas Piramal) • Traditional Advertising eg hoardings, promotional event eg by Strepsils • Unethical practices by some local players.

6. TAS Scheme of the presentation CUSTOMER INSIGHT  What customer insight did Sanofi-Aventis leverage to address the target market in India?  Are any of these insights applicable to other products and services across industry sectors? Customer Insights: • Doctors in rural areas: • Doctors enjoyed “godlike Power”. • Preferred certain brands • Doctors Unaware- leading to misdiagnosis. • No specialist doctors. All for one doctors • Latent demand for Knowledge: • Lacked advanced knowledge. • Not up to date with the recent developments. • Did not have opportunity to network and enhance their knowledge as compared to doctors in Tier 1 cities. • Sales in rural areas was in acute diseases rather than chronic (used to decide on product portfolio) • Customer Profile : Low income - Small but frequent purchases • Role of Chemists: Patients not always went to doctors. For small ailments they used medicines given by chemists.

7. TAS Scheme of the presentation CUSTOMER INSIGHT  What customer insight did Sanofi-Aventis leverage to address the target market in India?  Are any of these insights applicable to other products and services across industry sectors? Applicable in other sectors as well: • Purchases in rural areas are “influenced” rather than “informed” - Target influencers • Retailers influences purchases in rural markets, especially in FMCG markets. • Building an intangible brand value goes a long way in customer loyalty and retention. • Products such as mobile and computers had very little penetration until recently, resulting in high bargaining power of some few shopkeepers. • Create a different product portfolio to address the unique needs of BoP market • Smaller packs used by CavinCare to penetrate in daily wage earners market. (First company to introduce sachets packing in India)

8. TAS Scheme of the presentation SALES AND MARKETING  What challenges of marketing to the Bottom of Pyramid does this case highlight.  What innovative approaches for product, sales, marketing, and distribution does this case highlight.  How could businesses of Tata group companies apply these learnings? Take any business and detail your proposal. Challenges of marketing to BoP: • Logistics • Local competition • Need Quick fix solutions • Don't go to doctor - symptomatic treatments • Customised product portfolio that is attractive to the target segment • Emotional purchases

9. TAS Scheme of the presentation SALES AND MARKETING  What challenges of marketing to the Bottom of Pyramid does this case highlight.  What innovative approaches for product, sales, marketing, and distribution does this case highlight.  How could businesses of Tata group companies apply these learnings? Innovative approaches: • Workshop Solution - creating an intangible brand • Develop a product portfolio suitable for BoP • Acute Product Care Portfolio • Careful branding • Encashing Hoechst legacy • 3rd party manufacturers for cost advantage • Added a new sub-channel to distribution network

10. TAS Scheme of the presentation SALES AND MARKETING  What challenges of marketing to the Bottom of Pyramid does this case highlight.  What innovative approaches for product, sales, marketing, and distribution does this case highlight.  How could businesses of Tata group companies apply these learnings? Tata group company • Tata Chemicals - Tata Swachh • Sensitisation • Product portfolio • Branding • 3rd party manufacturing • Distribution network

11. TAS Scheme of the presentation FUTURE OUTLOOK  Identify the key challenges in sustaining the success of “Prayas” in and after 2011.  What would be your recommendations to address the challenges mentioned above.  Was the top management of Sanofi-Aventis right in wondering if such social models would yield profits similar to mainstream business models? How would you respond to such a dilemma? Key Challenges & Recommendations in sustaining Prayas • Growing Competition - competitors adopting similar measures aggressively • Scaling and expanding the initiative : vying for funds • Retaining and adding more KOLs/mentors/mentees • Retaining sales force • Digital interface - poor digital infra • Extending initiative to patients and pharmacies • Expanding product portfolio and increasing prescriptions

12. TAS THANK YOU!

13. TAS Annexure 1 Key features PureIt Swach PureIt Compact PureIt classic PureIt Autofill Swach Swach Smart Swach Magic Availability of different ranges and variety Three different varieties are available in the range Rs. 1000 to Rs. 3200 Three different varieties are available in the range Rs. 499 to Rs. 1498 Technology It is a 4 stage purification technology comprises of microfiber mesh for dirt, compact carbon trap for parasite & pesticide, germkill processor for bacteria & virus removal and a polisher for making the water tasty and odourless. TATA Swach® TSRF™ technology is based on nanotechnology efficient for removal of bacteria and viruses. Built around a bulb-like water purifier made of natural elements like rice husk ash impregnated with nano-silver particles, Cost Rs. 1000 Rs. 2000 Rs. 3200 Rs. 1498 (including extra bulb) Rs. 1213 (including extra bulb) Rs. 499 Refill / operational cost Rs. 280/ 1000 litres Rs. 550/ 2250 litres Rs. 550/ 2250 litres Rs.299 / 3000 litres Capacity of the purifier 14 litres 23 litres 18 litres Time taken for purification 9litres/1-5 hours 3-4litres/hour Purification life of the bulb/germkill kit 1000 litres 2250 litres/1500 litres 3000 litres End of life indicator Yes Yes Auto shut off when unsafe to use Yes Yes Running water Not required Both with & without Not required Water wastage No No Clear taste, removes odour Yes, other than high saltiness Yes, other than high saltiness Gas/electricity/any additives/boiling Not required Not required Plumbing or expensive installation & maintenance required Not required Not required Removal of salt / TDS Not done Not done Certification CTFTRI, Mysore, IPHA, Kolkata, IPHE, NEERI,SPDL, Glasgow, SHTM, University of London etc. CTFTRI, Mysore, IADFAC, Bangalore,Microtech Services (Wessex) Ltd, UK,AES, UK, Vitens Laboratory, Netherlands etc

14. TAS Annexure 2: Sanofi performance • Market capitalisation of INR 10k crores currently • Ranked 17 among Indian pharma firms

Add a comment

Related presentations

Related pages

Sanofi Aventis India Prayas | Upcoming 2015 2016

Upcoming 2015 2016 › Sanofi Aventis India Prayas Sanofi-aventis launches PRAYAS, an endeavor to meet rural India's Sanofi-aventis launches PRAYAS, an ...
Read more

Sanofi Aventis India Linkedin Login | Upcoming 2015 2016

Upcoming 2015 2016 › Sanofi Aventis India Linkedin Login Sanofi | LinkedIn Sanofi is a global life sciences company committed to improving access to ...
Read more

TAS : Bittersweet Experiences | Failed once. Failed twice ...

... 2016 TAS 2016 Alfred, Batman, ... TAS is kind enough to arrange ... 92 years old 4 story building that have shaped India’s corporate ...
Read more

Mohit Gupta | Facebook

Mohit Gupta is on Facebook. Join Facebook to connect with Mohit Gupta and others you may know. ... Class of 2014 · Delhi, India ...
Read more

Company | BehaveNet

Company Share this with ... 11/03/2016 - Clozapine REMS: McKesson Exposed; 10/27/2016 - Not Your Father’s Referral; 10/20/2016 - The Secret of REMS ...
Read more

Pharma Sector - Edel | Sanofi | Pharmaceutical Industry

Pharma Sector - Edel - Download as PDF File (.pdf), Text File (.txt) or read online.
Read more

Aventis | LinkedIn

Country Procurement Head at Sanofi Aventis Pakistan Limited Past Strategic Procurement Manager at Merck ... International trade at Abbott India Limited, ...
Read more

Sanofi Aventis | LinkedIn

Sanofi Aventis Articles, experts, jobs, and more: get all the professional insights you need on LinkedIn
Read more